State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Thyroid (Late Stage^), 2018-2022

All Races (includes Hispanic), Male, All Ages

Sorted by Percentlate

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

Colorado²

• Rate : The incidence rate is 3.4 with a 95% confidence interval from 3.1 to 3.7 and 105 average annual cases over 2018-2022.
• CI*Rank ⋔ : 8 (2, 22)
• Percent of Cases with Late Stage :

New Mexico⁷

• Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.1 to 4.1 and 40 average annual cases over 2018-2022.
• CI*Rank ⋔ : 4 (1, 25)
• Percent of Cases with Late Stage :

Hawaii⁷

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.2 to 3.3 and 23 average annual cases over 2018-2022.
• CI*Rank ⋔ : 34 (6, 48)
• Percent of Cases with Late Stage :

California⁷

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 3.0 to 3.2 and 634 average annual cases over 2018-2022.
• CI*Rank ⋔ : 17 (10, 25)
• Percent of Cases with Late Stage :

Nevada²

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.4 to 3.2 and 48 average annual cases over 2018-2022.
• CI*Rank ⋔ : 28 (9, 44)
• Percent of Cases with Late Stage :

Maryland²

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.5 to 3.1 and 92 average annual cases over 2018-2022.
• CI*Rank ⋔ : 26 (11, 40)
• Percent of Cases with Late Stage :

Illinois⁷

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.3 and 211 average annual cases over 2018-2022.
• CI*Rank ⋔ : 15 (7, 26)
• Percent of Cases with Late Stage :

Idaho⁷

• Rate : The incidence rate is 3.4 with a 95% confidence interval from 2.9 to 3.9 and 33 average annual cases over 2018-2022.
• CI*Rank ⋔ : 9 (1, 34)
• Percent of Cases with Late Stage :

Oregon²

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.5 to 3.2 and 66 average annual cases over 2018-2022.
• CI*Rank ⋔ : 22 (8, 41)
• Percent of Cases with Late Stage :

Wisconsin²

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 2.9 to 3.5 and 105 average annual cases over 2018-2022.
• CI*Rank ⋔ : 13 (4, 28)
• Percent of Cases with Late Stage :

Washington¹

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.5 to 3.0 and 116 average annual cases over 2018-2022.
• CI*Rank ⋔ : 29 (13, 40)
• Percent of Cases with Late Stage :

Texas⁷

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.6 to 2.8 and 389 average annual cases over 2018-2022.
• CI*Rank ⋔ : 32 (21, 38)
• Percent of Cases with Late Stage :

Arizona²

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.6 to 3.0 and 109 average annual cases over 2018-2022.
• CI*Rank ⋔ : 27 (13, 39)
• Percent of Cases with Late Stage :

Nebraska²

• Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.1 to 4.1 and 36 average annual cases over 2018-2022.
• CI*Rank ⋔ : 5 (1, 28)
• Percent of Cases with Late Stage :

Rhode Island²

• Rate : The incidence rate is 3.4 with a 95% confidence interval from 2.8 to 4.2 and 20 average annual cases over 2018-2022.
• CI*Rank ⋔ : 7 (1, 39)
• Percent of Cases with Late Stage :

North Carolina²

• Rate : The incidence rate is 2.4 with a 95% confidence interval from 2.2 to 2.6 and 132 average annual cases over 2018-2022.
• CI*Rank ⋔ : 41 (31, 47)
• Percent of Cases with Late Stage :

Missouri²

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.6 to 3.1 and 94 average annual cases over 2018-2022.
• CI*Rank ⋔ : 23 (11, 39)
• Percent of Cases with Late Stage :

Connecticut⁷

• Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.3 to 4.1 and 71 average annual cases over 2018-2022.
• CI*Rank ⋔ : 3 (1, 18)
• Percent of Cases with Late Stage :

Minnesota²

• Rate : The incidence rate is 3.0 with a 95% confidence interval from 2.8 to 3.3 and 93 average annual cases over 2018-2022.
• CI*Rank ⋔ : 19 (6, 35)
• Percent of Cases with Late Stage :

Vermont²

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.0 to 3.8 and 10 average annual cases over 2018-2022.
• CI*Rank ⋔ : 24 (1, 50)
• Percent of Cases with Late Stage :

Florida²

• Rate : The incidence rate is 2.6 with a 95% confidence interval from 2.5 to 2.8 and 327 average annual cases over 2018-2022.
• CI*Rank ⋔ : 35 (23, 39)
• Percent of Cases with Late Stage :

New York⁷

• Rate : The incidence rate is 4.0 with a 95% confidence interval from 3.8 to 4.1 and 419 average annual cases over 2018-2022.
• CI*Rank ⋔ : 1 (1, 6)
• Percent of Cases with Late Stage :

South Dakota²

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 2.7 to 4.4 and 15 average annual cases over 2018-2022.
• CI*Rank ⋔ : 6 (1, 42)
• Percent of Cases with Late Stage :

New Hampshire²

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.2 to 3.3 and 21 average annual cases over 2018-2022.
• CI*Rank ⋔ : 31 (5, 48)
• Percent of Cases with Late Stage :

South Carolina²

• Rate : The incidence rate is 2.1 with a 95% confidence interval from 1.8 to 2.3 and 58 average annual cases over 2018-2022.
• CI*Rank ⋔ : 47 (37, 50)
• Percent of Cases with Late Stage :

Indiana²

• Rate : The incidence rate is 2.4 with a 95% confidence interval from 2.2 to 2.7 and 87 average annual cases over 2018-2022.
• CI*Rank ⋔ : 40 (24, 47)
• Percent of Cases with Late Stage :

Utah⁷

• Rate : The incidence rate is 3.8 with a 95% confidence interval from 3.4 to 4.3 and 58 average annual cases over 2018-2022.
• CI*Rank ⋔ : 2 (1, 16)
• Percent of Cases with Late Stage :

Montana²

• Rate : The incidence rate is 3.4 with a 95% confidence interval from 2.7 to 4.1 and 21 average annual cases over 2018-2022.
• CI*Rank ⋔ : 10 (1, 40)
• Percent of Cases with Late Stage :

Wyoming²

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 1.9 to 3.7 and 9 average annual cases over 2018-2022.
• CI*Rank ⋔ : 33 (1, 50)
• Percent of Cases with Late Stage :

Michigan²

• Rate : The incidence rate is 2.5 with a 95% confidence interval from 2.3 to 2.7 and 133 average annual cases over 2018-2022.
• CI*Rank ⋔ : 39 (26, 46)
• Percent of Cases with Late Stage :

Massachusetts²

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 2.9 to 3.5 and 122 average annual cases over 2018-2022.
• CI*Rank ⋔ : 14 (4, 27)
• Percent of Cases with Late Stage :

Iowa⁷

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.7 to 3.5 and 53 average annual cases over 2018-2022.
• CI*Rank ⋔ : 18 (4, 37)
• Percent of Cases with Late Stage :

New Jersey⁷

• Rate : The incidence rate is 3.3 with a 95% confidence interval from 3.1 to 3.6 and 165 average annual cases over 2018-2022.
• CI*Rank ⋔ : 11 (3, 21)
• Percent of Cases with Late Stage :

Virginia²

• Rate : The incidence rate is 2.3 with a 95% confidence interval from 2.1 to 2.5 and 106 average annual cases over 2018-2022.
• CI*Rank ⋔ : 42 (31, 48)
• Percent of Cases with Late Stage :

Maine²

• Rate : The incidence rate is 3.0 with a 95% confidence interval from 2.4 to 3.6 and 24 average annual cases over 2018-2022.
• CI*Rank ⋔ : 20 (2, 45)
• Percent of Cases with Late Stage :

Kansas²

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.4 to 3.2 and 43 average annual cases over 2018-2022.
• CI*Rank ⋔ : 25 (8, 44)
• Percent of Cases with Late Stage :

Mississippi²

• Rate : The incidence rate is 1.8 with a 95% confidence interval from 1.5 to 2.1 and 27 average annual cases over 2018-2022.
• CI*Rank ⋔ : 49 (42, 51)
• Percent of Cases with Late Stage :

Tennessee²

• Rate : The incidence rate is 2.2 with a 95% confidence interval from 2.0 to 2.4 and 81 average annual cases over 2018-2022.
• CI*Rank ⋔ : 46 (35, 49)
• Percent of Cases with Late Stage :

Alaska²

• Rate : The incidence rate is 2.2 with a 95% confidence interval from 1.6 to 3.0 and 9 average annual cases over 2018-2022.
• CI*Rank ⋔ : 44 (9, 51)
• Percent of Cases with Late Stage :

Oklahoma²

• Rate : The incidence rate is 2.5 with a 95% confidence interval from 2.2 to 2.9 and 51 average annual cases over 2018-2022.
• CI*Rank ⋔ : 36 (18, 47)
• Percent of Cases with Late Stage :

North Dakota²

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 2.5 to 4.1 and 14 average annual cases over 2018-2022.
• CI*Rank ⋔ : 12 (1, 46)
• Percent of Cases with Late Stage :

Pennsylvania²

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.3 and 222 average annual cases over 2018-2022.
• CI*Rank ⋔ : 16 (7, 26)
• Percent of Cases with Late Stage :

Ohio²

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.5 to 2.9 and 171 average annual cases over 2018-2022.
• CI*Rank ⋔ : 30 (19, 40)
• Percent of Cases with Late Stage :

Kentucky⁷

• Rate : The incidence rate is 2.5 with a 95% confidence interval from 2.2 to 2.8 and 59 average annual cases over 2018-2022.
• CI*Rank ⋔ : 38 (21, 47)
• Percent of Cases with Late Stage :

Georgia⁷

• Rate : The incidence rate is 2.2 with a 95% confidence interval from 2.0 to 2.4 and 119 average annual cases over 2018-2022.
• CI*Rank ⋔ : 45 (35, 49)
• Percent of Cases with Late Stage :

Arkansas²

• Rate : The incidence rate is 2.0 with a 95% confidence interval from 1.7 to 2.4 and 33 average annual cases over 2018-2022.
• CI*Rank ⋔ : 48 (34, 50)
• Percent of Cases with Late Stage :

Louisiana⁷

• Rate : The incidence rate is 2.2 with a 95% confidence interval from 2.0 to 2.5 and 55 average annual cases over 2018-2022.
• CI*Rank ⋔ : 43 (31, 49)
• Percent of Cases with Late Stage :

Delaware²

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.2 to 3.6 and 15 average annual cases over 2018-2022.
• CI*Rank ⋔ : 21 (2, 48)
• Percent of Cases with Late Stage :

West Virginia²

• Rate : The incidence rate is 2.5 with a 95% confidence interval from 2.1 to 3.0 and 25 average annual cases over 2018-2022.
• CI*Rank ⋔ : 37 (12, 49)
• Percent of Cases with Late Stage :

Alabama²

• Rate : The incidence rate is 1.4 with a 95% confidence interval from 1.2 to 1.6 and 37 average annual cases over 2018-2022.
• CI*Rank ⋔ : 51 (49, 51)
• Percent of Cases with Late Stage :

Puerto Rico²

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.4 to 3.1 and 48 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage :

District of Columbia²

• Rate : The incidence rate is 1.6 with a 95% confidence interval from 1.0 to 2.4 and 5 average annual cases over 2018-2022.
• CI*Rank ⋔ : 50 (30, 51)
• Percent of Cases with Late Stage :

Notes:
Created by statecancerprofiles.cancer.gov on 03/30/2026 9:54 am.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. The rates used in CI*Rank are all age-adjusted to the 2000 US standard population using 19 age groups for SEER and NPCR areas. More information about methodology can be found on the CI*Rank website.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.

CI*Rank data for Puerto Rico is not available.